1084-P: Can Online CME Curriculum Impact Screening and Diagnosis of Cushing Syndrome in People with T2D? Results at Baseline and Immediately Post-education

Résumé fourni par la source

Introduction and Objective: Study seeks to assess if a series of online continuing medical education (CME) activities can improve screening for Cushing syndrome in people with difficult-to-control T2D by primary care physicians (PCPs) and diabetologists/endocrinologists (D/Es). Methods: Educational intervention included 3 activities- a 15-minute call-to-action on screening, a 30-minute panel discussion on prevalence and patient journey, and a 1-hour interactive case-based test and then teach case-based application activity. Before each activity, learners answered questions about their clinical practice and patients in the past 3 months as well as competence- and confidence-level questions (which are repeated immediately following participation). Additionally, after the activities, learners selected practice changes they intended to make from a select all that apply list with the option to select no changes. The activities launched in July 2024 and data were collected through December 2024. Results: 1,117 PCPs, 121 D/Es, and 643 NPs/PAs participated. 93% practice in the community setting. PCPs, D/Es and NPs/PAs report seeing an average of 8, 13, and 9 patients per month with T2D, respectively. Immediate impact of education demonstrates 46% improved their competence in screening and 175% more learners are now confident in their ability to recognize patients with difficult-to-control T2D who should be screened for hypercortisolism. Intended behavior changes include 31% of PCPs, 28% of D/Es and 30% of NPs/PAs intend to screen patients with difficult-to-control T2D for hypercortisolism. Conclusion: The pre-education data demonstrate gaps in screening in the presence of difficult-to-control T2D, as well as the positive impact of education on competence, confidence and intent to change practice. Impact of education on actual performance will be assessed over the coming months. Disclosure A. Larkin: None. A. Le: None. K.S. Lucero: None. Funding Independent educational grant from Corcept Therapeutics

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.